Tobramycin and vestibulotoxicity: retrospective analysis of four cases

por Vonk, S E M, Weersink, E J M, Majoor, C J, Kemper, E M
Publicado 2022

Quantitative Method for the Analysis of Ivacaftor, Hydroxymethyl Ivacaftor, Ivacaftor Carboxylate, Lumacaftor, and Tezacaftor in Plasma and Sputum Using Liquid Chromatography With...

por Vonk, Steffie E. M., van der Meer-Vos, Marloes, Bos, Lieuwe D. J., Neerincx, Anne H., Majoor, Christof J., Maitland-van der Zee, Anke-Hilse, Mathôt, Ron A. A., Kemper, E. Marleen
Publicado 2021

Real‐life efficacy and safety of elexacaftor/tezacaftor/ivacaftor on severe cystic fibrosis lung disease patients

por Kos, Renate, Neerincx, Anne H., Fenn, Dominic W., Brinkman, Paul, Lub, Rianne, Vonk, Steffie E. M., Roukema, Jolt, Reijers, Monique H., Terheggen‐Lagro, Suzanne W. J., Altenburg, Josje, Majoor, Christof J., Bos, Lieuwe D., Haarman, Eric G., Maitland‐van der Zee, Anke H.
Publicado 2022